Regulatory News FDA’s Brian Booth: “We need to reconsider our approach to dose selection” April 29, 2022Vol.48 No.17By Alice Tracey
LGBTQ+ Cancer Symposium aims to increase visibility of patients of all genders and sexualities April 29, 2022Vol.48 No.17By Alice Tracey
Regulatory News As part of Cancer Moonshot, FDA seeks to prohibit menthol cigarettes, flavored cigars April 29, 2022Vol.48 No.17By Paul Goldberg
FreeIn the Archives Recent contributors: Duke, Sarah Cannon, and the UA Center for the Study of Tobacco and Society April 29, 2022Vol.48 No.17
ACS recruitment of NCI’s William Dahut illustrates Karen Knudsen’s strategy April 22, 2022Vol.48 No.16By Paul Goldberg
Free Anticipating Ukrainian refugees in U.S., ACS, ASCO, Jefferson expand volunteer corps for cancer care resource hub April 22, 2022Vol.48 No.16By Alice Tracey
Conversation with The Cancer LetterFree Romania’s Csaba Dégi: We need to be proactive about psychosocial support, because Ukrainians are suffering April 22, 2022Vol.48 No.16By Matthew Bin Han Ong
COVID-19 & Cancer In-person cancer annual meetings during the COVID-19 pandemic: What you need to know April 22, 2022Vol.48 No.16By Matthew Bin Han Ong
Guest Editorial National marketing and communications network advances NCI cancer centers’ mission April 22, 2022Vol.48 No.16By Erin McElwain
Cancer History ProjectFree Odunsi, Pisters, Platanias, and Ulrich: How immigrating to the U.S. shaped their perspectives on oncology April 22, 2022Vol.48 No.16By Alexandria Carolan
